MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-06-2026
Myriad Genetics Total Current Liabilities 2011-2026 | MYGN
Annual Total Current Liabilities Myriad Genetics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 134 M | 164 M | 156 M | 137 M | 204 M | 146 M | 118 M | 102 M | 218 M | 72.3 M | 68.7 M | 80.6 M | 64.5 M | 45 M | 34.4 M | 27.5 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 218 M | 27.5 M | 111 M |
Total Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Burning Rock Biotech Limited
BNR
|
372 M | $ 18.56 | 10.74 % | $ 196 M |  China |
 |
Agilent Technologies
A
|
1.71 B | - | - | $ 34.4 B |  USA |
 |
Castle Biosciences
CSTL
|
68.7 M | $ 18.88 | 4.02 % | $ 547 M | USA |
 |
Fulgent Genetics
FLGT
|
72.9 M | $ 16.19 | 1.44 % | $ 490 M | USA |
 |
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Interpace Biosciences
IDXG
|
5.1 M | $ 1.8 | -5.26 % | $ 7.96 M | USA |
 |
Aspira Women's Health
AWH
|
3.46 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
66.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
89.8 M | $ 20.49 | -0.58 % | $ 1.09 B | USA |
 |
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Medpace Holdings
MEDP
|
1.34 B | $ 419.17 | -1.08 % | $ 12.1 B | USA |
 |
Check-Cap Ltd.
CHEK
|
4.05 M | - | - | $ 9.42 M |  Israel |
 |
Lantheus Holdings
LNTH
|
333 M | - | - | $ 6.5 B | USA |
 |
Mettler-Toledo International
MTD
|
1.2 B | $ 1 041.91 | 1.75 % | $ 21.5 B |  Schweiz |
 |
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | USA |
 |
Co-Diagnostics
CODX
|
3.54 M | $ 1.63 | 1.87 % | $ 2.17 M | USA |
 |
NeoGenomics
NEO
|
88.3 M | $ 8.36 | 1.21 % | $ 1.07 B | USA |
 |
National Research Corporation
NRC
|
36.6 M | $ 18.93 | 1.39 % | $ 424 M | USA |
 |
Natera
NTRA
|
310 M | $ 196.91 | 0.81 % | $ 19.4 B | USA |
 |
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | USA |
 |
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Charles River Laboratories International
CRL
|
1.12 B | $ 159.12 | -2.29 % | $ 7.89 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
641 M | - | - | $ 19.8 B | USA |
 |
Personalis
PSNL
|
39.6 M | $ 6.71 | 5.01 % | $ 599 M | USA |
 |
Guardant Health
GH
|
303 M | $ 98.66 | 0.19 % | $ 12.4 B | USA |
 |
Senseonics Holdings
SENS
|
24.3 M | $ 5.82 | 5.82 % | $ 243 M | USA |
 |
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
2.8 B | $ 117.09 | -0.25 % | $ 9.66 B |  Irlanda |
 |
Illumina
ILMN
|
1.55 B | $ 143.24 | -1.21 % | $ 22.8 B | USA |
 |
Soleno Therapeutics
SLNO
|
61.4 M | $ 52.99 | 0.08 % | $ 2.69 B | USA |
 |
QIAGEN N.V.
QGEN
|
512 M | - | - | $ 10.6 B |  Niderland |
 |
Twist Bioscience Corporation
TWST
|
91.4 M | $ 52.95 | -2.65 % | $ 3.17 B | USA |
 |
Biomerica
BMRA
|
1.74 M | $ 2.41 | 7.11 % | $ 5.54 M | USA |
 |
Thermo Fisher Scientific
TMO
|
15.2 B | $ 448.21 | 0.49 % | $ 169 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
2.82 B | $ 254.02 | -0.16 % | $ 21.1 B | USA |
 |
Waters Corporation
WAT
|
1.24 B | $ 333.21 | -0.51 % | $ 19.8 B | USA |
 |
Celcuity
CELC
|
44.2 M | $ 134.72 | 8.23 % | $ 6.3 B | USA |
 |
Motus GI Holdings
MOTS
|
3.27 M | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
174 M | $ 8.43 | -2.99 % | $ 1.83 B | USA |